Reverse merger · Completed · NAYA
NAYA Biosciences, Inc.
Reverse merger with INVO Bioscience, Inc. (INVO)
NAYA Biosciences, Inc. merged into INVO Bioscience, Inc. (INVO), a fertility healthcare services company (INVOcell), in a reverse merger that takes the private company public. The deal was announced on Oct 23, 2023 and closed on Oct 11, 2024. The combined company trades as NAYA Biosciences, Inc. (NAYA) on Nasdaq.
NAYA Biosciences, Inc. (later INVO Fertility) develops clinical-stage oncology and autoimmune therapies while continuing INVO's revenue-generating fertility clinic and device business.
- Status
- Completed
- Private company
- NAYA Biosciences, Inc.
- Public company
- INVO Bioscience, Inc. (INVO)
- Public company business before
- fertility healthcare services company (INVOcell)
- Announced
- Oct 23, 2023
- Closed
- Oct 11, 2024
- Combined company
- NAYA Biosciences, Inc. (NAYA)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Announcement 8-K Oct 26, 2023
- Announcement press release
- Closing 8-K Oct 15, 2024
- Closing press release
- All filings on EDGAR CIK 1417926
Other completed reverse mergers
- Lomond Therapeutics, Inc.into Venetian-1 Acquisition Corp. · Nov 1, 2024
- TuHURA Biosciences, Inc.into Kintara Therapeutics, Inc. · Oct 18, 2024
- Pharmagesic (Holdings) Inc. (Wex Pharmaceuticals)into Virios Therapeutics, Inc. · Oct 7, 2024
- OnKure, Inc.into Reneo Pharmaceuticals, Inc. · Oct 4, 2024
- Polomar Specialty Pharmacy, LLCinto Trustfeed Corp. · Sep 30, 2024
- Oruka Therapeutics, Inc.into ARCA biopharma, Inc. · Aug 29, 2024